North West Fund backs Evgen first close
Pharmaceutical business Evgen, a developer of a drug that may prevent and treat prostate cancer and other cancer, has closed a Series A investment round led by The North West Fund for Biomedical.
News
Pharmaceutical business Evgen, a developer of a drug that may prevent and treat prostate cancer and other cancer, has closed a Series A investment round led by The North West Fund for Biomedical.
News
News